Has Rajeev Dayal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,574 in general payments to Rajeev Dayal, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rajeev Dayal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rajeev Dayal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rajeev Dayal, MD

Vascular Surgery · Flushing, NYNPI 1457331613

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,274 of the $4,574 with a category attached, or 71.6%. 15 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 33.9% of the total. That places this record below the midpoint for vascular surgery clinicians in NY, where the typical reported total is $4,841.

$4,574in general payments, 2019–2025

Across 65 payments — averaging $70.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

W. L. Gore & Associates, Inc.$2K
Silk Road Medical, Inc.$866
Cook Medical LLC$438
Inari Medical, Inc.$401
Medtronic$271
Boston Scientific$247
plus $799 from 9 others

$2,105in research payments, 2019–2025

Across 1 payment — averaging $2105.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bard Peripheral Vascular, Inc.$2K

What the payments were for

Grants$2616%
Travel & lodging$1,03323%
Food & beverage$3,27472%
Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
W. L. Gore & Associates, Inc.	20	$1,552
Silk Road Medical, Inc.	6	$866
Cook Medical LLC	13	$438
Inari Medical, Inc.	3	$401
Medtronic(3 entities)	4	$271
Boston Scientific	2	$247
Terumo Medical Corporation	4	$223
Bard Peripheral Vascular, Inc.	2	$137
Bolton Medical Inc	1	$107
Endologix LLC	1	$74
Johnson & Johnson	2	$59
Cook Incorporated	1	$58
Smith+Nephew	2	$51
Cardiovascular Systems Inc.	3	$49
Tactile Systems Technology Inc	1	$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,574 in reported general payments places this provider in the 45th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024

$214,861

Medicare patients

516

Services billed

1,184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	13	$8,760
Cilostazol	32	$428
Diclofenac Sodium	13	$220
ClopidogrelClopidogrel Bisulfate	17	$128
Triamcinolone Acetonide	23	$126
Mupirocin	18	$94
Gabapentin	12	$79

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Flushing

Gary GelbfishNew York$1.9M
Sundaram RavikumarDobbs Ferry$1.8M
Antonios GasparisHuntington$1.5M
Sonya NoorBuffalo$991K
John LantisNew York$922K
Brian DerubertisNew York$714K
James McKinseyNew York$616K
Peter FariesNew York$494K
Robert RheeBrooklyn$338K
Ajit RaoNew York$294K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →